SIRT1 rs7896005 polymorphism affects major vascular outcomes, not all‐cause mortality, in Caucasians with type 2 diabetes: A 13‐year observational study
Open Access
- 29 January 2022
- journal article
- research article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 38 (4) , e3523
Abstract
Aims: SIRT1 exerts effects on ageing and lifespan, as well cardiovascular (CV) disease risk. SIRT1 gene is very polymorph with a few tagging single nucleotide polymorphisms (SNPs) so far identified. Some SNPs, including rs7896005, were associated with type 2 diabetes (T2DM). We aimed to ascertain whether this SNP may be associated with CV disease at baseline as well with these same outcomes and all‐cause mortality over a 13‐year follow‐up.Materials and Methods: Genotypes of SIRT1 gene were determined using TaqMan SNP assay.Results: Out of 905 T2DM, 9.1% had the AA genotype, 43.2% the AG, and 47.7% the GG. Hardy–Weinberg Equilibrium was met (minor allele frequency 0.306; p = 0.8899). At baseline, there was no difference across genotypes for sex, age, diabetes duration, CV risk factors, treatments, and microangiopathy. Major CV outcomes, myocardial infarction (MI), any coronary heart disease (CHD), and peripheral artery disease (PAD) were more frequent in GG than in AA/AG (p from 0.013 to 0.027), with no association with cerebrovascular events. By fully adjusted regression, GG remained independently related to major CV outcomes, MI, CHD, and PAD. Over follow‐up, we recorded 258 major CV events (28.5%; AA/AG 25.2%, GG 32.2%; p = 0.014) with an adjusted hazard ratio (HR) of GG versus AA/AG of 1.296 (95% CI 1.007–1.668, p = 0.044); 169 coronary events (18.7%; AA/AG 15.4%, GG 22.2%; p = 0.006) with HR 1.522 (1.113–2.080, p = 0.008); 79 (8.7%) hospitalisation for heart failure (AA/AG 7.0%, GG 10.6%; p = 0.045) and HR 1.457 (0.919–2.309, p = 0.109); 36 PAD (4.0%; AA/AG 2.3%, GG 5.8%; p = 0.007) with HR 2.225 (1.057–4.684, p = 0.035). No association was found with cerebrovascular events, end stage renal disease, and all‐cause mortality.Conclusions: The rs7896005 SNP of SIRT1 might play a role in cardiovascular disease, mainly CHD risk in T2DM. Results call for larger association studies as well as studies to ascertain mechanisms by which this variant confers increased risk.Keywords
This publication has 47 references indexed in Scilit:
- SIRT1 Polymorphism, Long-Term Survival and Glucose Tolerance in the General PopulationPLOS ONE, 2013
- The Interactive Effect of SIRT1 Promoter Region Polymorphism on Type 2 Diabetes Susceptibility in the North Indian PopulationPLOS ONE, 2012
- Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and ComplicationsDiabetic Medicine, 2012
- Variants in the SIRT1 Gene May Affect Diabetes Risk in Interaction With Prenatal Exposure to FamineDiabetes Care, 2012
- Association of Sirtuin 1 (SIRT1) Gene SNPs and Transcript Expression Levels With Severe ObesityObesity, 2012
- SIRT1 is associated with a decrease in acute insulin secretion and a sex specific increase in risk for type 2 diabetes in Pima IndiansMolecular Genetics and Metabolism, 2011
- Telomere maintenance genes SIRT1 and XRCC6 impact age-related decline in telomere length but only SIRT1 is associated with human longevityBiogerontology, 2011
- Association between single nucleotide polymorphisms within genes encoding sirtuin families and diabetic nephropathy in Japanese subjects with type 2 diabetesClinical and Experimental Nephrology, 2011
- Mammalian Sirtuins: Biological Insights and Disease RelevanceAnnual Review of Pathology: Mechanisms of Disease, 2010
- SIRT1 Genetic Variation Is Related to BMI and Risk of ObesityDiabetes, 2009